The Journal of Leukocyte Biology (JLB) will publish a special focus issue to include articles related to topics of the 14th World Congress on Inflammation, both review papers ("overviews") and original investigations. Selected contributions will be invited soon after the completion of the conference, and all submitted manuscripts will be peer-reviewed according to the high standards of the JLB.
The Journal of Leukocyte Biology (JLB) publishes original experimental and clinical research that provides new insights into the function of leukocytes and/or stromal cells at the molecular, structural, cellular and systemic level. The Journal scope includes all leukocytes (granulocytes, monocytes/macrophages, dendritic cells, T, B and innate lymphoid or NK/NKT cells) and/or leukocyte products together with associated stromal (endothelial, epithelial) cells studied in vitro and in the context of innate and adaptive immunity, development, homeostasis, host-pathogen interactions, immunotherapy and immunopathogenesis (in both vertebrate models and/or human studies). Pathologies of interest include immunodeficiency, autoimmunity, allergy, cancer, trauma, infections, inflammatory and iatrogenic diseases. JLB also publishes basic, translational and clinical reviews as well as commentaries on current journal content.
Participants may submit their work for the dedicated issue according to the following schedule:
14th World Congress on Inflammation – for September 2020
Mtg: September 15–19, 2019, Sydney, Australia
(Guest Editor: Matt Sweet)
Invite by October 1; Respond by October 15
Submit by January 15, 2020
Review by March 16, 2020
Revise by: April 20, re-review by June 1, 2020
Accept by: June 1, 2020, PUBLISH in print September 2020